Treatment of Cystic Fibrosis and Other Rare Lung Diseases

Nonfiction, Health & Well Being, Medical, Specialties, Pulmonary & Thoracic, Medical Science, Pharmacology
Cover of the book Treatment of Cystic Fibrosis and Other Rare Lung Diseases by , Springer Basel
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783034809771
Publisher: Springer Basel Publication: January 28, 2017
Imprint: Springer Language: English
Author:
ISBN: 9783034809771
Publisher: Springer Basel
Publication: January 28, 2017
Imprint: Springer
Language: English

This volume describes the pathogenesis and pathophysiology of several pulmonary diseases as well as their treatment. It also discusses the underlying genetic and molecular biological basis, which opens the way for new treatments for these conditions.

It focuses on the treatment of cystic fibrosis including CFTR (cystic fibrosis transmembrane-conductance regulator) modulator therapies, drug therapies that augment airway surface liquid as well as anti-inflammatory and anti-infective therapies. Further topics include long-term, low-dose macrolide therapy for diffuse panbronchiolitis; novel agents for previously untreatable idiopathic pulmonary fibrosis; possible new treatments for pulmonary alveolar proteinosis (PAP); and multiple novel therapeutic targets for treating lymphangiomyomatosis. Research into these conditions has led to major advances in our understanding of the underlying genetic and molecular basis of this disease, and to dramatic improvements in survival and quality of life for affected individuals.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This volume describes the pathogenesis and pathophysiology of several pulmonary diseases as well as their treatment. It also discusses the underlying genetic and molecular biological basis, which opens the way for new treatments for these conditions.

It focuses on the treatment of cystic fibrosis including CFTR (cystic fibrosis transmembrane-conductance regulator) modulator therapies, drug therapies that augment airway surface liquid as well as anti-inflammatory and anti-infective therapies. Further topics include long-term, low-dose macrolide therapy for diffuse panbronchiolitis; novel agents for previously untreatable idiopathic pulmonary fibrosis; possible new treatments for pulmonary alveolar proteinosis (PAP); and multiple novel therapeutic targets for treating lymphangiomyomatosis. Research into these conditions has led to major advances in our understanding of the underlying genetic and molecular basis of this disease, and to dramatic improvements in survival and quality of life for affected individuals.

More books from Springer Basel

Cover of the book Bortezomib in the Treatment of Multiple Myeloma by
Cover of the book Circulating microRNAs in Disease Diagnostics and their Potential Biological Relevance by
Cover of the book Urban Geology by
Cover of the book The Philosophy of Mathematics and Logic in the 1920s and 1930s in Poland by
Cover of the book Berichte zur Resistenzmonitoringstudie 2009 by
Cover of the book Dynamische Systeme by
Cover of the book Fish Vaccines by
Cover of the book The Scholar and the State: In Search of Van der Waerden by
Cover of the book Drugs for HER-2-positive Breast Cancer by
Cover of the book Indacaterol by
Cover of the book Alpine Treelines by
Cover of the book Problem-Solving Methods in Combinatorics by
Cover of the book Influenza Virus Sialidase - A Drug Discovery Target by
Cover of the book The Power of the Terroir: the Case Study of Prosecco Wine by
Cover of the book Real Quaternionic Calculus Handbook by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy